Gotham Asset Management Reduces Thermo Fisher Scientific Holdings

Hedge fund cuts stake in medical research company by 10% in Q3

Mar. 17, 2026 at 9:10am

Got story updates? Submit your updates here. ›

Gotham Asset Management LLC reduced its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 10.0% in the third quarter, according to a regulatory filing. The hedge fund now owns 71,776 shares of the medical research company's stock, valued at $34.8 million at the end of the reporting period.

Why it matters

Thermo Fisher Scientific is a major player in the medical research and diagnostics industry, so changes in institutional ownership of its stock can provide insights into investor sentiment and market trends in this sector.

The details

Gotham Asset Management, a New York-based hedge fund, sold 7,986 shares of Thermo Fisher Scientific during the third quarter. The firm now holds a $34.8 million stake in the company, down from a previous holding valued at $38.7 million. Thermo Fisher Scientific's stock price has fluctuated in recent quarters amid broader market volatility.

  • Gotham Asset Management reduced its Thermo Fisher Scientific holdings in the third quarter of 2026.

The players

Gotham Asset Management LLC

A New York-based hedge fund that manages investments across various sectors.

Thermo Fisher Scientific Inc.

A global provider of scientific instrumentation, reagents, and services that support research, clinical, and industrial laboratories.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Gotham Asset Management's Thermo Fisher Scientific holdings suggests the hedge fund may have a more cautious outlook on the medical research company's near-term prospects, though the stock remains a significant part of its portfolio.